Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model.
Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model.
复制标题
DOI:
10.3390/pharmaceutics13050633
复制
发表时间:
2021-04-29
期刊:
影响因子:
5.4
通讯作者:
Billack B
中科院分区:
文献类型:
--
作者:
Menon S;Liang X;Vartak R;Patel K;Di Stefano A;Cacciatore I;Marinelli L;Billack B
Carvacrol (CAR), a phenolic monoterpenoid, has been extensively investigated for its antimicrobial and antifungal activity. As a result of its poor physicochemical properties, water soluble carvacrol prodrugs (WSCPs) with improved water solubility were previously synthesized and found to possess antimicrobial activity. Here, three novel CAR analogs, WSCP1, WSCP2, and WSCP3, were tested against fluconazole (FLU)-sensitive and -resistant strains where they showed greater antifungal activity than CAR against C. albicans. The probable mechanism by which the CAR prodrugs exert the antifungal activity was studied. Results from medium acidification assays demonstrated that the CAR and its synthetically designed prodrugs inhibit the yeast plasma membrane H+-ATPase (Pma1p), an essential target in fungi. In other words, in vitro data indicated that CAR analogs can prove to be a better alternative to CAR considering their improved water solubility. In addition, CAR and WSCP1 were developed into intravaginal formulations and administered at test doses of 50 mg/kg in a mouse model of vulvovaginal candidiasis (VVC). Whereas the CAR and WSCP1 formulations both exhibited antifungal efficacy in the mouse model of VVC, the WSCP1 formulation was superior to CAR, showing a remarkable decrease in infection by ~120-fold compared to the control (infected, untreated animals). Taken together, a synthetically designed prodrug of CAR, namely WSCP1, proved to be a possible solution for poorly water-soluble drugs, an inhibitor of an essential yeast pump in vitro and an effective and promising antifungal agent in vivo.
登录
查看更多内容
DOI:
10.3390/ph10040086
发表时间:
2017-11-02
期刊:
Pharmaceuticals (Basel, Switzerland)
影响因子:
--
作者:
Nazzaro F;Fratianni F;Coppola R;Feo V
通讯作者:
Feo V
DOI:
10.1590/s0036-46652008000100002
发表时间:
2008-02-01
期刊:
Revista do Instituto de Medicina Tropical de São Paulo
影响因子:
--
作者:
Koga-Ito, Cristiane Yumi;Lyon, Juliana Pereira;Resende, Maria Aparecida de
通讯作者:
Resende, Maria Aparecida de
影响因子:
--
作者:
Conti, Heather R;Huppler, Anna R;Whibley, Natasha;Gaffen, Sarah L
通讯作者:
Gaffen, Sarah L
影响因子:
4.9
作者:
Perea, S;López-Ribot, JL;Patterson, TF
通讯作者:
Patterson, TF
影响因子:
3.1
作者:
Fidel, PL;Cutright, J;Steele, C
通讯作者:
Steele, C